Free Trial

Travere Therapeutics (TVTX) Short Interest Ratio & Short Volume

→ Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad)
Free TVTX Stock Alerts
$6.19
+0.13 (+2.15%)
(As of 12:45 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Travere Therapeutics Short Interest Data

Current Short Interest
12,810,000 shares
Previous Short Interest
11,800,000 shares
Change Vs. Previous Month
+8.56%
Dollar Volume Sold Short
$70.84 million
Short Interest Ratio
10.3 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
76,130,000 shares
Percentage of Shares Shorted
16.83%
Today's Trading Volume
196,395 shares
Average Trading Volume
1,254,310 shares
Today's Volume Vs. Average
16%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Travere Therapeutics ?

Sign up to receive the latest short interest report for Travere Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

TVTX Short Interest Over Time

TVTX Days to Cover Over Time

TVTX Percentage of Float Shorted Over Time

Travere Therapeutics Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202412,810,000 shares $70.84 million +8.6%N/A10.3 $5.53
4/15/202411,800,000 shares $74.58 million +11.3%N/A9.9 $6.32
3/31/202410,600,000 shares $81.73 million +5.3%N/A8.8 $7.71
3/15/202410,070,000 shares $75.42 million -1.9%N/A8.2 $7.49
2/29/202410,260,000 shares $77.57 million +5.1%N/A7.5 $7.56
2/15/20249,760,000 shares $85.30 million -1.7%N/A6.7 $8.74
1/31/20249,930,000 shares $88.67 million +2.3%N/A6.3 $8.93
1/15/20249,710,000 shares $92.54 million -2.1%N/A5.8 $9.53
12/31/20239,920,000 shares $89.18 million +2.9%N/A5.9 $8.99
12/15/20239,640,000 shares $83.48 million -3.1%N/A5.8 $8.66
11/30/20239,950,000 shares $62.49 million -6.7%N/A5 $6.28
11/15/202310,660,000 shares $65.77 million +21.0%N/A5.9 $6.17
10/31/20238,810,000 shares $57.09 million +0.5%N/A5.2 $6.48
10/15/20238,770,000 shares $62.27 million +4.2%N/A5.6 $7.10
9/30/20238,420,000 shares $75.27 million -6.9%N/A5.8 $8.94
9/15/20239,040,000 shares $123.76 million +5.7%N/A6.7 $13.69
8/31/20238,550,000 shares $122.09 million +5.6%N/A8.3 $14.28
8/15/20238,100,000 shares $123.12 million +0.4%N/A7.6 $15.20
7/31/20238,070,000 shares $138.72 million -2.7%N/A7.3 $17.19
7/15/20238,290,000 shares $126.92 million -2.5%N/A6.5 $15.31
6/30/20238,500,000 shares $130.56 million +11.0%N/A6.3 $15.36
6/15/20237,660,000 shares $131.75 million +4.9%N/A5.4 $17.20
5/31/20237,300,000 shares $130.60 million -3.2%N/A5.4 $17.89
5/15/20237,540,000 shares $123.20 million -4.1%N/A4.7 $16.34
4/30/20237,860,000 shares $169.54 million -3.7%N/A4.7 $21.57
4/15/20238,160,000 shares $165.81 million -4.5%N/A5.6 $20.32
3/31/20238,540,000 shares $192.06 million +14.8%N/A5.7 $22.49
3/15/20237,440,000 shares $158.25 million -1.6%N/A5.4 $21.27
2/28/20237,560,000 shares $167.53 million +9.9%N/A5.7 $22.16
2/15/20236,880,000 shares $138.43 million -7.7%N/A5.8 $20.12
1/31/20237,450,000 shares $166.88 million -0.9%N/A8.8 $22.40
1/15/20237,520,000 shares $152.81 million -10.3%N/A9.1 $20.32
12/30/20228,380,000 shares $176.23 million +3.1%N/A10 $21.03
12/15/20228,130,000 shares $150.41 million -1.2%N/A9.7 $18.50
11/30/20228,230,000 shares $165.67 million +5.9%N/A10.6 $20.13
11/15/20227,770,000 shares $167.13 million -1.2%N/A10.4 $21.51
10/31/20227,860,000 shares $170.40 million +23.0%13.0%10.9 $21.68
10/15/20226,390,000 shares $132.15 million -6.2%10.6%8.4 $20.68
9/30/20226,810,000 shares $167.80 million +3.0%11.3%10.3 $24.64
9/15/20226,610,000 shares $179.79 million -0.5%11.0%9.9 $27.20
This Apple-like Innovator is Revolutionizing Healthcare (Ad)

AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.

Click here to learn more about the booming eHealth industry
8/31/20226,640,000 shares $177.69 million -10.2%11.1%9 $26.76
8/15/20227,390,000 shares $211.28 million +7.9%12.3%9.7 $28.59
7/31/20226,850,000 shares $161.25 million +2.4%11.5%7.9 $23.54
7/15/20226,690,000 shares $163.97 million -5.0%11.2%8.4 $24.51
6/30/20227,040,000 shares $170.58 million +6.2%11.8%8.6 $24.23
6/15/20226,630,000 shares $160.18 million -10.4%11.1%8 $24.16
5/31/20227,400,000 shares $172.49 million -12.6%12.4%8.9 $23.31
5/15/20228,470,000 shares $187.86 million +3.7%14.2%9.7 $22.18
4/30/20228,170,000 shares $205.31 million +14.1%13.8%10.5 $25.13
4/15/20227,160,000 shares $212.22 million +0.7%12.1%9.3 $29.64
3/31/20227,110,000 shares $183.22 million -6.5%12.0%9.8 $25.77
3/15/20227,600,000 shares $181.72 million +29.3%12.8%11.5 $23.91
2/28/20225,880,000 shares $160.29 million -1.7%10.0%9.1 $27.26
2/15/20225,980,000 shares $171.39 million +11.4%10.5%11 $28.66
1/31/20225,370,000 shares $147.68 million +8.5%9.3%10.6 $27.50
1/15/20224,950,000 shares $136.32 million -15.5%8.5%9.3 $27.54
12/31/20215,860,000 shares $181.89 million -6.4%N/A0 $31.04
12/15/20216,260,000 shares $182.48 million +0.6%10.8%11.6 $29.15
11/30/20216,220,000 shares $177.58 million +3.0%10.7%10.5 $28.55
11/15/20216,040,000 shares $177.39 million -1.2%10.4%9.7 $29.37
10/29/20216,110,000 shares $176.03 million +0.5%10.1%5 $28.81
10/15/20216,080,000 shares $148.96 million -6.9%10.2%5.1 $24.50
9/30/20216,530,000 shares $158.35 million -5.6%10.9%5.4 $24.25
9/15/20216,920,000 shares $162.83 million -3.1%11.5%5.4 $23.53
8/31/20217,140,000 shares $155.87 million +6.7%11.9%5.5 $21.83
8/13/20216,690,000 shares $103.36 million -1.6%11.2%4.9 $15.45
7/30/20216,800,000 shares $93.50 million +2.6%11.4%8.3 $13.75
7/15/20216,630,000 shares $90.83 million -1.5%11.1%8 $13.70
6/30/20216,730,000 shares $98.19 million +23.0%11.3%8.3 $14.59
6/15/20215,470,000 shares $81.67 million +19.4%9.2%7.5 $14.93
5/28/20214,580,000 shares $69.48 million -0.4%7.7%7 $15.17
5/14/20214,600,000 shares $86.94 million -3.2%7.7%8.7 $18.90
4/30/20214,750,000 shares $117.85 million -1.5%8.0%8.2 $24.81
4/15/20214,820,000 shares $122.48 million -6.4%8.1%7.7 $25.41
3/31/20215,150,000 shares $125.25 million +20.9%8.6%8.3 $24.32
3/15/20214,260,000 shares $122.43 million +3.2%7.2%6.9 $28.74
2/26/20214,130,000 shares $122.66 million -1.7%7.0%6.9 $29.70
2/12/20214,200,000 shares $116.72 million -0.7%7.4%7.3 $27.79
1/29/20214,230,000 shares $109.09 million -2.8%8.4%8.9 $25.79
1/15/20214,350,000 shares $126.67 million No Change8.6%11.1 $29.12

TVTX Short Interest - Frequently Asked Questions

What is Travere Therapeutics' current short interest?

Short interest is the volume of Travere Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 12,810,000 shares of TVTX short. Learn More on Travere Therapeutics' current short interest.

What is a good short interest ratio for Travere Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TVTX shares currently have a short interest ratio of 10.0. Learn More on Travere Therapeutics's short interest ratio.

Is Travere Therapeutics' short interest increasing or decreasing?

Travere Therapeutics saw a increase in short interest in April. As of April 30th, there was short interest totaling 12,810,000 shares, an increase of 8.6% from the previous total of 11,800,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Travere Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Travere Therapeutics: Larimar Therapeutics, Inc. (6.11%), Astria Therapeutics, Inc. (10.24%), Verve Therapeutics, Inc. (30.19%), KalVista Pharmaceuticals, Inc. (13.13%), Oculis Holding AG (0.20%), Applied Therapeutics, Inc. (3.91%), Y-mAbs Therapeutics, Inc. (7.47%), Aerovate Therapeutics, Inc. (10.43%), Arbutus Biopharma Co. (3.08%), Adlai Nortye Ltd. (0.03%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Travere Therapeutics stock?

Short selling TVTX is an investing strategy that aims to generate trading profit from Travere Therapeutics as its price is falling. TVTX shares are trading up $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Travere Therapeutics?

A short squeeze for Travere Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TVTX, which in turn drives the price of the stock up even further.

How often is Travere Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TVTX, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (NASDAQ:TVTX) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Elon to Transform U.S. Economy?
Porter & Company
Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!
Priority Gold
Does this make you sick?
Allegiance Gold
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
This Apple-like Innovator is Revolutionizing Healthcare
Wall Street Star
**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1!
Huge Alerts